Table 4.
Gene | CpG Site | Overall | Age <25 years N=56 |
Age ≥25 years N=78 |
---|---|---|---|---|
| ||||
HR (95% CI)†‡ | ||||
IGFAS | 5 | 0.41 (0.23, 0.76) | 0.41 (0.17, 0.97) | 0.65 (0.34, 1.25) |
Kv | DMR§ | 0.83 (0.55, 1.26) | 0.73 (0.40, 1.34) | 0.86 (0.52, 1.41) |
MEG3 | DMR§ | 0.89 (0.57, 1.38) | 1.53 (0.80, 2.94) | 0.54 (0.32, 0.92) |
PEG10 | DMR§ | 0.80 (0.65, 0.98) | 0.60 (0.43, 0.85) | 0.88 (0.69, 1.12) |
CIN = cervical intraepithelial neoplasia; 151 cases with at least one follow-up visit
HR=Hazard ratio; 95% CI= 95% confidence intervals; continuous methylation levels rescaled using interquartile range for each CpG site
Adjusted for race, current smoking, continuous parity and history of oral contraceptive use
DMR = differentially methylated region (median of all CpG sites
MEG3 intronic differentially methylated region